Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets.
Ontology highlight
ABSTRACT: BACKGROUND:Severe asthma is a chronic disease contributing to disproportionate disease morbidity and mortality. From the year of 2007, many genome-wide association studies (GWAS) have documented a large number of asthma-associated genetic variants and related genes. Nevertheless, the molecular mechanism of these identified variants involved in asthma or severe asthma risk remains largely unknown. METHODS:In the current study, we systematically integrated 3 independent expression quantitative trait loci (eQTL) data (N?=?1977) and a large-scale GWAS summary data of moderate-to-severe asthma (N?=?30,810) by using the Sherlock Bayesian analysis to identify whether expression-related variants contribute risk to severe asthma. Furthermore, we performed various bioinformatics analyses, including pathway enrichment analysis, PPI network enrichment analysis, in silico permutation analysis, DEG analysis and co-expression analysis, to prioritize important genes associated with severe asthma. RESULTS:In the discovery stage, we identified 1129 significant genes associated with moderate-to-severe asthma by using the Sherlock Bayesian analysis. Two hundred twenty-eight genes were prominently replicated by using MAGMA gene-based analysis. These 228 replicated genes were enriched in 17 biological pathways including antigen processing and presentation (Corrected P?=?4.30?×?10-?6), type I diabetes mellitus (Corrected P?=?7.09?×?10-?5), and asthma (Corrected P?=?1.72?×?10-?3). With the use of a series of bioinformatics analyses, we highlighted 11 important genes such as GNGT2, TLR6, and TTC19 as authentic risk genes associated with moderate-to-severe/severe asthma. With respect to GNGT2, there were 3 eSNPs of rs17637472 (PeQTL?=?2.98?×?10-?8 and PGWAS?=?3.40?×?10-?8), rs11265180 (PeQTL?=?6.0?×?10-?6 and PGWAS?=?1.99?×?10-?3), and rs1867087 (PeQTL?=?1.0?×?10-?4 and PGWAS?=?1.84?×?10-?5) identified. In addition, GNGT2 is significantly expressed in severe asthma compared with mild-moderate asthma (P?=?0.045), and Gngt2 shows significantly distinct expression patterns between vehicle and various glucocorticoids (Anova P?=?1.55?×?10-?6). CONCLUSIONS:Our current study provides multiple lines of evidence to support that these 11 identified genes as important candidates implicated in the pathogenesis of severe asthma.
SUBMITTER: Dong Z
PROVIDER: S-EPMC7568423 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA